C - Chemistry – Metallurgy – 12 – P
Patent
C - Chemistry, Metallurgy
12
P
C12P 21/04 (2006.01) A61K 31/785 (2006.01)
Patent
CA 2627821
A time-released formulation of vancomycin. The invention also includes a vancomycin composition having a reduced level of histamine and a process for reducing the level of histamine in a vancomycin composition. The invention also includes a pharmaceutical composition containing vancomycin that reduces the incidence of Red Man Syndrome, phlebitis, and hypotension. The invention further includes a histamine-free growth media that supports growth of Amycolatopsis orientalis and the fermentation of vancomycin.
L'invention concerne une formulation de vancomycine à libération régulée. L'invention concerne également une composition de vancomycine à teneur réduite en histamine et un procédé de réduction du niveau d'histamine dans une composition de vancomycine. L'invention concerne également une composition pharmaceutique contenant de la vancomycine qui réduit l'incidence du syndrome de l'homme rouge, de la phlébite, et de l'hypotension. L'invention concerne en outre un milieu de croissance exempt d'histamine supportant la croissance d'Amycolatopsis orientalis et la fermentation de vancomycine.
Blessing Richard
May Thomas B.
Menon Sukumaran K.
Ostrow David H.
Hospira Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Vancomycin formulations having reduced amount of histamine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vancomycin formulations having reduced amount of histamine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vancomycin formulations having reduced amount of histamine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1443955